Similar articles

• MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization.

  Son HY, Jeong HK, Apostolopoulos V, Kim CW. Son HY, et al. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221112358. doi: 10.1177/03946320221112358. Int J Immunopathol Pharmacol. 2022. Retraction in: Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320241310709. doi: 10.1177/03946320241310709. PMID: 35839304 Free PMC article. Retracted.
• Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1).

  Johnen H, Kulbe H, Pecher G. Johnen H, et al. Cancer Immunol Immunother. 2001 Sep;50(7):356-60. doi: 10.1007/s002620100212. Cancer Immunol Immunother. 2001. PMID: 11676395 Free PMC article.
• Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.

  Zhang S, Zhang H, Shi H, Yu X, Kong W, Li W. Zhang S, et al. Hum Immunol. 2008 Apr-May;69(4-5):250-8. doi: 10.1016/j.humimm.2008.02.006. Epub 2008 Apr 4. Hum Immunol. 2008. PMID: 18486759
• A review on development of MUC1-based cancer vaccine.

  Gao T, Cen Q, Lei H. Gao T, et al. Biomed Pharmacother. 2020 Dec;132:110888. doi: 10.1016/j.biopha.2020.110888. Epub 2020 Oct 21. Biomed Pharmacother. 2020. PMID: 33113416 Review.
• Expression of mucin antigens in human cancers and its relationship with malignancy potential.

  Yonezawa S, Sato E. Yonezawa S, et al. Pathol Int. 1997 Dec;47(12):813-30. doi: 10.1111/j.1440-1827.1997.tb03713.x. Pathol Int. 1997. PMID: 9503463 Review.